Selecta Biosciences Inc. (SELB) NASDAQ

$0.71 0.02 (2.27%)

Market Cap: $107.22M

As of 05/25/22 04:00 PM EDT. Market closed.

(SELB)

Selecta Biosciences Inc. (SELB) NASDAQ

$0.71 0.02 (2.27%)

Market Cap: $107.22M

As of 05/25/22 04:00 PM EDT. Market closed.

Selecta Biosciences Inc. is leveraging its clinically validated ImmTOR™ platform to develop tolerogenic therapies that selectively mitigate unwanted immune responses. With a proven ability to induce tolerance to highly immunogenic proteins, ImmTOR has the potential to amplify the efficacy of biologic therapies, including redosing of life-saving gene therapies, as well as restore the body's ... read more

Selecta Biosciences Inc. is leveraging its clinically validated ImmTOR™ platform to develop tolerogenic therapies that selectively mitigate unwanted immune responses. With a proven ability to induce tolerance to highly immunogenic proteins, ImmTOR has the potential to amplify the efficacy of biologic therapies, including redosing of life-saving gene therapies, as well as restore the body's natural self-tolerance in autoimmune diseases. The company's first program aimed at addressing immunogenicity to AAV gene therapies is expected to enter clinical trials in early 2021 in partnership with AskBio for the treatment of methylmalonic acidemia (MMA), a rare metabolic disorder. A wholly-owned program focused on addressing IgA nephropathy driven by ImmTOR and a therapeutic enzyme is also in development among additional product candidates. Selecta recently licensed its Phase 3 clinical product candidate, SEL-212, in chronic refractory gout to Sobi. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Carsten Brunn
Full Time Employees
44
CEO Compensation (Base)
$42,308
CEO Compensation (Total)
$5.61M
URL
Address
65 Grove Street, Massachusetts, Watertown, 02472.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Carsten Brunn
Full Time Employees
44
CEO Compensation (Base)
$42,308
CEO Compensation (Total)
$5.61M
Address
65 Grove Street, Massachusetts, Watertown, 02472.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
KEY STATS
Open
$0
Previous Close
$0.69
Days Range
$0.67 - $0.72
52 week range
$0.65 - $5.28
Volume
863,726
Avg. Volume (30 days)
1,635,423
Market Cap
$107.22M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
151,809,416
Open
$0
Previous Close
$0.69
Days Range
$0.67 - $0.72
52 week range
$0.65 - $5.28
Volume
863,726
Avg. Volume (30 days)
1,635,423
Market Cap
$107.22M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
151,809,416

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR SELECTA BIOSCIENCES INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
BARABE TIMOTHY C Director May 09, 2022 Buy $0.77 50,000 38,720 250,013 May 11, 2022, 04:21 PM
BARABE TIMOTHY C Director Jan 14, 2022 Option Exercise $2.10 10,000 21,000 200,013 Jan 18, 2022, 04:19 PM
TRABER PETER G Chief Medical Officer Jan 05, 2022 Sale $3.09 3,226 9,955 251,355 Jan 07, 2022, 04:18 PM
Kishimoto Takashi Kei Chief Scientific Officer Jan 05, 2022 Sale $3.09 3,416 10,541 268,353 Jan 07, 2022, 04:18 PM
Johnston Lloyd P. Chief Operations Officer Jan 05, 2022 Sale $3.09 3,416 10,541 175,299 Jan 07, 2022, 04:18 PM
Brunn Carsten President and CEO Jan 05, 2022 Sale $3.09 13,597 41,959 517,958 Jan 07, 2022, 04:17 PM
SPRINGER TIMOTHY A Director Dec 15, 2021 Buy $2.99 211,190 631,099 23,186,890 Dec 17, 2021, 04:36 PM
TRABER PETER G Chief Medical Officer Dec 10, 2021 Sale $2.99 4,083 12,196 164,381 Dec 14, 2021, 05:17 PM
Kishimoto Takashi Kei Chief Scientific Officer Dec 10, 2021 Sale $2.99 4,370 13,053 199,769 Dec 14, 2021, 05:16 PM
Johnston Lloyd P. Chief Operations Officer Dec 10, 2021 Sale $2.99 4,370 13,053 106,715 Dec 14, 2021, 05:16 PM
Brunn Carsten President and CEO Dec 10, 2021 Sale $2.99 17,196 51,363 305,255 Dec 14, 2021, 05:16 PM
SPRINGER TIMOTHY A Director Dec 10, 2021 Buy $2.99 58,681 175,439 22,961,108 Dec 13, 2021, 05:16 PM
SPRINGER TIMOTHY A Director Dec 09, 2021 Buy $3.06 3,748,000 11,468,880 22,902,427 Dec 13, 2021, 05:16 PM
SPRINGER TIMOTHY A Director Dec 13, 2021 Buy $2.98 14,592 43,491 22,975,700 Dec 13, 2021, 05:16 PM
Tan Kevin Chief Financial Officer Dec 02, 2021 Buy $3.03 5,000 15,127 5,000 Dec 06, 2021, 04:25 PM
DeSilva Nishan M Director Dec 02, 2021 Buy $2.96 7,000 20,723 7,000 Dec 06, 2021, 04:25 PM
COX CARRIE SMITH Director Dec 03, 2021 Buy $2.95 17,200 50,664 82,881 Dec 06, 2021, 04:25 PM
Brunn Carsten President and CEO Dec 02, 2021 Sale $2.96 4,746 14,065 284,951 Dec 03, 2021, 04:28 PM
TRABER PETER G Chief Medical Officer Oct 13, 2021 Sale $4.39 3,636 15,962 154,714 Oct 15, 2021, 06:08 PM
Kishimoto Takashi Kei Chief Scientific Officer Oct 13, 2021 Sale $4.39 3,892 17,086 190,389 Oct 15, 2021, 06:07 PM
Johnston Lloyd P. Chief Operations Officer Oct 13, 2021 Sale $4.39 3,892 17,086 97,335 Oct 15, 2021, 06:07 PM
Brunn Carsten President and CEO Oct 13, 2021 Sale $4.39 15,313 67,224 278,759 Oct 15, 2021, 06:07 PM
Brunn Carsten President and CEO Sep 02, 2021 Sale $4.51 4,523 20,399 229,372 Sep 03, 2021, 04:18 PM
BARABE TIMOTHY C Director Aug 18, 2021 Buy $4.00 9,000 36,000 190,013 Aug 20, 2021, 06:09 PM
BARABE TIMOTHY C Director Mar 26, 2021 Buy $4.10 10,000 41,000 181,013 Mar 30, 2021, 04:50 PM
TRABER PETER G Chief Medical Officer Mar 18, 2021 Buy $4.50 10,000 45,000 98,000 Mar 19, 2021, 05:34 PM
TRABER PETER G Chief Medical Officer Mar 17, 2021 Buy $4.53 10,000 45,295 88,000 Mar 19, 2021, 05:34 PM
Johnston Lloyd P. COO and SVP, R&D Mar 17, 2021 Sale $4.45 15,128 67,312 87,477 Mar 19, 2021, 05:33 PM
Brunn Carsten President and CEO Mar 02, 2021 Sale $4.26 5,461 23,257 216,826 Mar 03, 2021, 05:21 PM
Johnston Lloyd P. COO and SVP, R&D Feb 11, 2021 Option Exercise $0.63 44,871 28,269 102,605 Feb 16, 2021, 06:10 PM
TRABER PETER G Chief Medical Officer Dec 14, 2020 Buy $3.24 40,000 129,424 40,000 Dec 16, 2020, 04:31 PM
Brunn Carsten President and CEO Dec 02, 2020 Sale $3.35 3,323 11,134 101,350 Dec 03, 2020, 04:22 PM
Kishimoto Takashi Kei Chief Scientific Officer Oct 23, 2020 Option Exercise $2.77 30,000 83,100 126,149 Oct 27, 2020, 05:13 PM
SPRINGER TIMOTHY A Director Oct 22, 2020 Buy $2.63 1,770,204 4,656,699 13,486,460 Oct 23, 2020, 05:12 PM
SPRINGER TIMOTHY A Director Oct 21, 2020 Buy $2.50 880,000 2,199,472 11,716,256 Oct 23, 2020, 05:12 PM
SPRINGER TIMOTHY A Director Oct 23, 2020 Buy $2.71 994,488 2,699,737 14,480,948 Oct 23, 2020, 05:12 PM
SPRINGER TIMOTHY A Director Oct 20, 2020 Buy $2.21 910,000 2,013,193 10,836,256 Oct 20, 2020, 06:07 PM
SPRINGER TIMOTHY A Director Oct 19, 2020 Buy $2.36 759,500 1,795,002 9,926,256 Oct 20, 2020, 06:07 PM
SPRINGER TIMOTHY A Director Oct 16, 2020 Buy $2.42 218,196 528,034 9,166,756 Oct 20, 2020, 06:07 PM
SPRINGER TIMOTHY A Director Oct 09, 2020 Buy $2.00 276,703 552,465 8,948,560 Oct 14, 2020, 04:18 PM
SPRINGER TIMOTHY A Director Oct 08, 2020 Buy $1.89 530,441 1,000,836 8,671,857 Oct 08, 2020, 05:50 PM
SPRINGER TIMOTHY A Director Oct 07, 2020 Buy $1.65 654,953 1,078,577 8,141,416 Oct 08, 2020, 05:50 PM
SPRINGER TIMOTHY A Director Oct 06, 2020 Buy $1.68 2,000,000 3,365,800 7,486,463 Oct 08, 2020, 05:50 PM
BARABE TIMOTHY C Director Oct 06, 2020 Buy $1.68 50,000 83,985 171,013 Oct 08, 2020, 04:25 PM
Brunn Carsten President and CEO Sep 02, 2020 Sale $2.39 3,364 8,035 93,735 Sep 03, 2020, 04:29 PM
BARABE TIMOTHY C Director Jun 24, 2020 Option Exercise $1.46 32,840 47,946 121,013 Jun 26, 2020, 04:21 PM
Brunn Carsten President and CEO Jun 02, 2020 Sale $3.86 3,253 12,557 86,162 Jun 03, 2020, 04:42 PM
BARABE TIMOTHY C Director Mar 17, 2020 Buy $2.00 5,000 10,000 88,173 Mar 19, 2020, 05:16 PM
Brunn Carsten President and CEO Mar 03, 2020 Sale $3.86 3,374 13,011 78,477 Mar 03, 2020, 04:25 PM
Johnston Lloyd P. COO and SVP, R&D Jan 16, 2020 Option Exercise $0.47 5,128 2,410 16,734 Jan 21, 2020, 05:21 PM
BARABE TIMOTHY C Director Dec 23, 2019 Option Exercise $1.46 65,681 95,894 83,173 Dec 26, 2019, 05:30 PM
SPRINGER TIMOTHY A Director Dec 23, 2019 Option Exercise $1.46 3,940,887 5,753,695 5,486,463 Dec 26, 2019, 05:30 PM
COX CARRIE SMITH Director Dec 23, 2019 Option Exercise $1.46 65,681 95,894 65,681 Dec 26, 2019, 05:30 PM
Myers Scott Dunseth Director Dec 23, 2019 Option Exercise $1.46 39,409 57,537 80,845 Dec 26, 2019, 05:29 PM
Brunn Carsten President and CEO Dec 02, 2019 Sale $1.53 14,272 21,809 70,914 Dec 03, 2019, 04:20 PM
SPRINGER TIMOTHY A Director Aug 20, 2019 Option Exercise $1.81 1,100,000 1,991,000 1,545,576 Aug 20, 2019, 04:33 PM
SPRINGER TIMOTHY A Director Aug 20, 2019 Option Exercise $1.81 1,600,000 2,896,000 6,056,597 Aug 20, 2019, 04:33 PM
Smolinski Stephen Chief Commercial Officer Aug 20, 2019 Option Exercise $1.81 13,812 25,000 13,812 Aug 20, 2019, 04:32 PM
Myers Scott Dunseth Director Aug 20, 2019 Option Exercise $1.81 41,436 74,999 41,436 Aug 20, 2019, 04:32 PM
Kogan Elona Esq. General Counsel Aug 20, 2019 Option Exercise $1.81 82,872 149,998 182,872 Aug 20, 2019, 04:32 PM
Kishimoto Takashi Kei Chief Scientific Officer Aug 20, 2019 Option Exercise $1.81 50,000 90,500 86,114 Aug 20, 2019, 04:31 PM
Brunn Carsten President and CEO Aug 20, 2019 Option Exercise $1.81 41,436 74,999 41,436 Aug 20, 2019, 04:31 PM
ZENNER PATRICK J Director Aug 20, 2019 Option Exercise $1.81 55,248 99,999 55,248 Aug 20, 2019, 04:29 PM
SPRINGER TIMOTHY A Director Aug 14, 2019 Buy $1.74 10,000 17,415 86,418 Aug 16, 2019, 04:18 PM
BARABE TIMOTHY C Director Aug 13, 2019 Buy $1.72 10,000 17,200 17,492 Aug 15, 2019, 04:19 PM
Johnston Lloyd P. COO and SVP, R&D Jul 23, 2019 Option Exercise $0.47 10,000 4,700 11,606 Jul 25, 2019, 04:15 PM
Farokhzad Omid Director Jan 25, 2019 Buy $1.50 83,333 125,000 83,333 Mar 29, 2019, 04:17 PM
SPRINGER TIMOTHY A Director Jan 25, 2019 Buy $1.50 66,666 99,999 76,418 Mar 29, 2019, 04:15 PM
SPRINGER TIMOTHY A Director Jan 25, 2019 Buy $1.50 4,000,000 6,000,000 4,456,597 Mar 29, 2019, 04:15 PM
SPRINGER TIMOTHY A Director Nov 10, 2017 Buy $9.03 4,752 42,906 9,752 Mar 29, 2019, 04:15 PM
Kishimoto Takashi Kei Chief Scientific Officer Jan 07, 2019 Option Exercise $2.77 36,114 100,036 36,114 Feb 21, 2019, 04:29 PM
Nashat Amir Director Jan 25, 2019 Buy $1.50 1,166,666 1,749,999 2,676,234 Jan 29, 2019, 04:37 PM
Sands Earl Chief Medical Officer Nov 17, 2017 Buy $10.26 7,500 76,967 7,500 Nov 21, 2017, 04:08 PM
SPRINGER TIMOTHY A Director Nov 14, 2017 Buy $9.27 57,598 534,095 461,349 Nov 16, 2017, 05:14 PM
Abraham David GC, CCO & Corporate Secretary Nov 14, 2017 Buy $9.25 5,405 49,996 5,405 Nov 14, 2017, 09:58 PM
CAUTREELS WERNER President and CEO Nov 13, 2017 Buy $9.31 20,000 186,250 321,203 Nov 14, 2017, 09:57 PM
SPRINGER TIMOTHY A Director Nov 10, 2017 Buy $9.04 26,338 238,097 403,751 Nov 13, 2017, 06:19 PM
SPRINGER TIMOTHY A Director Nov 09, 2017 Buy $9.34 5,000 46,681 5,000 Nov 13, 2017, 06:19 PM
SPRINGER TIMOTHY A Director Nov 09, 2017 Buy $9.35 22,000 205,659 377,413 Nov 13, 2017, 06:19 PM
BARABE TIMOTHY C Director Nov 10, 2017 Buy $9.00 2,500 22,505 7,492 Nov 13, 2017, 06:18 PM
BARABE TIMOTHY C Director Nov 09, 2017 Buy $9.73 2,500 24,335 4,992 Nov 13, 2017, 06:18 PM
Nashat Amir Director Sep 26, 2017 Sale $18.91 70,226 1,328,079 1,550,478 Sep 28, 2017, 05:10 PM
Nashat Amir Director Sep 25, 2017 Sale $18.99 37,175 705,883 1,618,242 Sep 26, 2017, 05:19 PM
Nashat Amir Director Sep 22, 2017 Sale $19.26 42,036 809,781 1,654,114 Sep 26, 2017, 05:19 PM
Siewers David CFO and Treasurer Sep 20, 2017 Option Exercise $0.63 16,424 10,347 14,230 Sep 22, 2017, 05:30 PM
Siewers David CFO and Treasurer Sep 20, 2017 Sale $20.00 16,424 328,480 0 Sep 22, 2017, 05:30 PM
Nashat Amir Director Sep 20, 2017 Sale $20.03 42,610 853,389 1,795,587 Sep 22, 2017, 04:09 PM
Nashat Amir Director Sep 21, 2017 Sale $19.86 104,577 2,076,826 1,694,676 Sep 22, 2017, 04:09 PM
Johnston Lloyd P. COO and SVP, R&D Jun 15, 2017 Option Exercise $0.47 10,512 4,941 12,118 Jul 10, 2017, 04:19 PM
Johnston Lloyd P. COO and SVP, R&D Jun 15, 2017 Sale $17.04 10,512 179,141 1,606 Jul 10, 2017, 04:19 PM
Johnston Lloyd P. COO and SVP, R*D Jul 03, 2017 Option Exercise $2.77 5,959 16,506 7,565 Jul 06, 2017, 04:05 PM
Johnston Lloyd P. COO and SVP, R*D Jul 03, 2017 Sale $19.10 5,959 113,806 7,465 Jul 06, 2017, 04:05 PM
Siewers David Chief Financial Officer Jun 30, 2017 Option Exercise $0.63 7,420 4,675 7,420 Jul 05, 2017, 12:00 AM
Siewers David Chief Financial Officer Jun 30, 2017 Sale $20.00 7,420 148,405 0 Jul 05, 2017, 12:00 AM
Siewers David Chief Financial Officer Jun 29, 2017 Option Exercise $0.57 9,616 5,443 9,652 Jun 30, 2017, 04:33 PM
Siewers David Chief Financial Officer Jun 29, 2017 Sale $20.00 9,652 193,042 36 Jun 30, 2017, 04:33 PM
SPRINGER TIMOTHY A Director Jun 27, 2017 Buy $17.71 338,791 5,999,988 355,413 Jun 28, 2017, 04:36 PM
Keller Peter Chief Business Officer Jun 27, 2017 Option Exercise $0.63 4,595 2,895 5,000 Jun 28, 2017, 04:35 PM
Keller Peter Chief Business Officer Jun 27, 2017 Sale $19.30 4,595 88,681 405 Jun 28, 2017, 04:35 PM
Siewers David Chief Financial Officer Jun 26, 2017 Sale $20.00 6,886 137,720 36 Jun 28, 2017, 04:35 PM
Johnston Lloyd P. COO and SVP, R*D Jun 15, 2017 Option Exercise $0.47 20,512 9,641 22,118 Jun 19, 2017, 04:12 PM
Johnston Lloyd P. COO and SVP, R*D Jun 15, 2017 Sale $17.00 20,512 348,640 1,606 Jun 19, 2017, 04:12 PM
SPRINGER TIMOTHY A Director Jun 01, 2017 Buy $13.75 518 7,123 16,622 Jun 02, 2017, 04:05 PM
SPRINGER TIMOTHY A Director May 18, 2017 Buy $14.00 4,860 68,040 16,104 May 19, 2017, 04:06 PM
SPRINGER TIMOTHY A Director May 17, 2017 Buy $14.01 11,244 157,483 11,244 May 19, 2017, 04:06 PM
KANIA EDWIN M JR Director May 16, 2017 Sale $14.00 266,795 3,735,130 560,067 May 16, 2017, 05:28 PM
Johnston Lloyd P. COO AND SVP, R&D Apr 17, 2017 Option Exercise $0.39 13,205 5,150 14,811 Apr 18, 2017, 05:18 PM
Johnston Lloyd P. COO AND SVP, R&D Apr 17, 2017 Sale $13.95 13,205 184,210 1,606 Apr 18, 2017, 05:18 PM
Farokhzad Omid Director Mar 23, 2017 Option Exercise $3.92 60,000 235,108 188,004 Mar 27, 2017, 04:02 PM
Johnston Lloyd P. COO AND SVP, R&D Jan 23, 2017 Option Exercise $0.39 15,000 5,850 16,606 Jan 30, 2017, 04:54 PM
Johnston Lloyd P. COO AND SVP, R&D Jan 23, 2017 Sale $14.01 15,000 210,106 5,496 Jan 30, 2017, 04:54 PM
Kishimoto Takashi Kei Chief Scientific Officer Dec 28, 2016 Option Exercise $2.77 10,000 27,700 10,000 Dec 30, 2016, 06:07 PM
Kishimoto Takashi Kei Chief Scientific Officer Dec 28, 2016 Sale $17.55 10,000 175,500 0 Dec 30, 2016, 06:07 PM
Abraham David CCO, Gen.Counsel, Corp.Sec. Dec 21, 2016 Option Exercise $0.47 12,280 5,772 14,844 Dec 23, 2016, 02:19 PM
Abraham David CCO, Gen.Counsel, Corp.Sec. Dec 21, 2016 Sale $18.00 14,844 267,192 0 Dec 23, 2016, 02:19 PM
Keller Peter Chief Business Officer Dec 19, 2016 Sale $18.58 4,723 87,753 405 Dec 21, 2016, 07:14 PM
ORBIMED ADVISORS LLC Director Jun 27, 2016 Buy $14.00 550,000 7,700,000 1,825,415 Jun 29, 2016, 08:55 PM
RUSNANO 10% Owner Jun 27, 2016 Buy $14.00 107,143 1,500,002 157,009 Jun 29, 2016, 06:14 PM
GORDON CARL L Director Jun 27, 2016 Buy $14.00 550,000 7,700,000 1,825,415 Jun 29, 2016, 04:49 PM
ORBIMED ADVISORS LLC Director Jun 27, 2016 Buy $14.00 550,000 7,700,000 1,825,415 Jun 29, 2016, 04:49 PM
Osage University Partners II, L.P. 10% Owner Jun 27, 2016 Buy $14.00 350,000 4,900,000 862,543 Jun 29, 2016, 04:47 PM
Nanodimension Management Ltd 10% Owner Jun 27, 2016 Buy $14.00 385,000 5,390,000 1,045,957 Jun 29, 2016, 04:46 PM
TAS Partners, LLC Director Jun 27, 2016 Buy $14.00 710,000 9,940,000 1,237,028 Jun 29, 2016, 04:45 PM
Nashat Amir Director Jun 27, 2016 Buy $14.00 150,000 2,100,000 1,836,703 Jun 29, 2016, 04:45 PM
Polaris Venture Management Co. V, L.L.C. 10% Owner Jun 27, 2016 Buy $14.00 150,000 2,100,000 1,836,703 Jun 29, 2016, 04:44 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
BARABE TIMOTHY C Director 05/09/2022 38,720
BARABE TIMOTHY C Director 01/14/2022 21,000
TRABER PETER G Chief Medical Officer 01/05/2022 9,955
Kishimoto Takashi Kei Chief Scientific Officer 01/05/2022 10,541
Johnston Lloyd P. Chief Operations Officer 01/05/2022 10,541
Brunn Carsten President and CEO 01/05/2022 41,959
SPRINGER TIMOTHY A Director 12/15/2021 631,099
TRABER PETER G Chief Medical Officer 12/10/2021 12,196
Kishimoto Takashi Kei Chief Scientific Officer 12/10/2021 13,053
Johnston Lloyd P. Chief Operations Officer 12/10/2021 13,053
Brunn Carsten President and CEO 12/10/2021 51,363
SPRINGER TIMOTHY A Director 12/10/2021 175,439
SPRINGER TIMOTHY A Director 12/09/2021 11,468,880
SPRINGER TIMOTHY A Director 12/13/2021 43,491
Tan Kevin Chief Financial Officer 12/02/2021 15,127
DeSilva Nishan M Director 12/02/2021 20,723
COX CARRIE SMITH Director 12/03/2021 50,664
Brunn Carsten President and CEO 12/02/2021 14,065
TRABER PETER G Chief Medical Officer 10/13/2021 15,962
Kishimoto Takashi Kei Chief Scientific Officer 10/13/2021 17,086
Johnston Lloyd P. Chief Operations Officer 10/13/2021 17,086
Brunn Carsten President and CEO 10/13/2021 67,224
Brunn Carsten President and CEO 09/02/2021 20,399
BARABE TIMOTHY C Director 08/18/2021 36,000
BARABE TIMOTHY C Director 03/26/2021 41,000
TRABER PETER G Chief Medical Officer 03/18/2021 45,000
TRABER PETER G Chief Medical Officer 03/17/2021 45,295
Johnston Lloyd P. COO and SVP, R&D 03/17/2021 67,312
Brunn Carsten President and CEO 03/02/2021 23,257
Johnston Lloyd P. COO and SVP, R&D 02/11/2021 28,269
TRABER PETER G Chief Medical Officer 12/14/2020 129,424
Brunn Carsten President and CEO 12/02/2020 11,134
Kishimoto Takashi Kei Chief Scientific Officer 10/23/2020 83,100
SPRINGER TIMOTHY A Director 10/22/2020 4,656,699
SPRINGER TIMOTHY A Director 10/21/2020 2,199,472
SPRINGER TIMOTHY A Director 10/23/2020 2,699,737
SPRINGER TIMOTHY A Director 10/20/2020 2,013,193
SPRINGER TIMOTHY A Director 10/19/2020 1,795,002
SPRINGER TIMOTHY A Director 10/16/2020 528,034
SPRINGER TIMOTHY A Director 10/09/2020 552,465
SPRINGER TIMOTHY A Director 10/08/2020 1,000,836
SPRINGER TIMOTHY A Director 10/07/2020 1,078,577
SPRINGER TIMOTHY A Director 10/06/2020 3,365,800
BARABE TIMOTHY C Director 10/06/2020 83,985
Brunn Carsten President and CEO 09/02/2020 8,035
BARABE TIMOTHY C Director 06/24/2020 47,946
Brunn Carsten President and CEO 06/02/2020 12,557
BARABE TIMOTHY C Director 03/17/2020 10,000
Brunn Carsten President and CEO 03/03/2020 13,011
Johnston Lloyd P. COO and SVP, R&D 01/16/2020 2,410
BARABE TIMOTHY C Director 12/23/2019 95,894
SPRINGER TIMOTHY A Director 12/23/2019 5,753,695
COX CARRIE SMITH Director 12/23/2019 95,894
Myers Scott Dunseth Director 12/23/2019 57,537
Brunn Carsten President and CEO 12/02/2019 21,809
SPRINGER TIMOTHY A Director 08/20/2019 1,991,000
SPRINGER TIMOTHY A Director 08/20/2019 2,896,000
Smolinski Stephen Chief Commercial Officer 08/20/2019 25,000
Myers Scott Dunseth Director 08/20/2019 74,999
Kogan Elona Esq. General Counsel 08/20/2019 149,998
Kishimoto Takashi Kei Chief Scientific Officer 08/20/2019 90,500
Brunn Carsten President and CEO 08/20/2019 74,999
ZENNER PATRICK J Director 08/20/2019 99,999
SPRINGER TIMOTHY A Director 08/14/2019 17,415
BARABE TIMOTHY C Director 08/13/2019 17,200
Johnston Lloyd P. COO and SVP, R&D 07/23/2019 4,700
Farokhzad Omid Director 01/25/2019 125,000
SPRINGER TIMOTHY A Director 01/25/2019 99,999
SPRINGER TIMOTHY A Director 01/25/2019 6,000,000
SPRINGER TIMOTHY A Director 11/10/2017 42,906
Kishimoto Takashi Kei Chief Scientific Officer 01/07/2019 100,036
Nashat Amir Director 01/25/2019 1,749,999
Sands Earl Chief Medical Officer 11/17/2017 76,967
SPRINGER TIMOTHY A Director 11/14/2017 534,095
Abraham David GC, CCO & Corporate Secretary 11/14/2017 49,996
CAUTREELS WERNER President and CEO 11/13/2017 186,250
SPRINGER TIMOTHY A Director 11/10/2017 238,097
SPRINGER TIMOTHY A Director 11/09/2017 46,681
SPRINGER TIMOTHY A Director 11/09/2017 205,659
BARABE TIMOTHY C Director 11/10/2017 22,505
BARABE TIMOTHY C Director 11/09/2017 24,335
Nashat Amir Director 09/26/2017 1,328,079
Nashat Amir Director 09/25/2017 705,883
Nashat Amir Director 09/22/2017 809,781
Siewers David CFO and Treasurer 09/20/2017 10,347
Siewers David CFO and Treasurer 09/20/2017 328,480
Nashat Amir Director 09/20/2017 853,389
Nashat Amir Director 09/21/2017 2,076,826
Johnston Lloyd P. COO and SVP, R&D 06/15/2017 4,941
Johnston Lloyd P. COO and SVP, R&D 06/15/2017 179,141
Johnston Lloyd P. COO and SVP, R*D 07/03/2017 16,506
Johnston Lloyd P. COO and SVP, R*D 07/03/2017 113,806
Siewers David Chief Financial Officer 06/30/2017 4,675
Siewers David Chief Financial Officer 06/30/2017 148,405
Siewers David Chief Financial Officer 06/29/2017 5,443
Siewers David Chief Financial Officer 06/29/2017 193,042
SPRINGER TIMOTHY A Director 06/27/2017 5,999,988
Keller Peter Chief Business Officer 06/27/2017 2,895
Keller Peter Chief Business Officer 06/27/2017 88,681
Siewers David Chief Financial Officer 06/26/2017 137,720
Johnston Lloyd P. COO and SVP, R*D 06/15/2017 9,641
Johnston Lloyd P. COO and SVP, R*D 06/15/2017 348,640
SPRINGER TIMOTHY A Director 06/01/2017 7,123
SPRINGER TIMOTHY A Director 05/18/2017 68,040
SPRINGER TIMOTHY A Director 05/17/2017 157,483
KANIA EDWIN M JR Director 05/16/2017 3,735,130
Johnston Lloyd P. COO AND SVP, R&D 04/17/2017 5,150
Johnston Lloyd P. COO AND SVP, R&D 04/17/2017 184,210
Farokhzad Omid Director 03/23/2017 235,108
Johnston Lloyd P. COO AND SVP, R&D 01/23/2017 5,850
Johnston Lloyd P. COO AND SVP, R&D 01/23/2017 210,106
Kishimoto Takashi Kei Chief Scientific Officer 12/28/2016 27,700
Kishimoto Takashi Kei Chief Scientific Officer 12/28/2016 175,500
Abraham David CCO, Gen.Counsel, Corp.Sec. 12/21/2016 5,772
Abraham David CCO, Gen.Counsel, Corp.Sec. 12/21/2016 267,192
Keller Peter Chief Business Officer 12/19/2016 87,753
ORBIMED ADVISORS LLC Director 06/27/2016 7,700,000
RUSNANO 10% Owner 06/27/2016 1,500,002
GORDON CARL L Director 06/27/2016 7,700,000
ORBIMED ADVISORS LLC Director 06/27/2016 7,700,000
Osage University Partners II, L.P. 10% Owner 06/27/2016 4,900,000
Nanodimension Management Ltd 10% Owner 06/27/2016 5,390,000
TAS Partners, LLC Director 06/27/2016 9,940,000
Nashat Amir Director 06/27/2016 2,100,000
Polaris Venture Management Co. V, L.L.C. 10% Owner 06/27/2016 2,100,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2022
09/30/2021
12.74%
2Q
03/31/2022
03/31/2021
15.20%
4Q
03/31/2022
12/31/2020
26.06%
5Q
03/31/2022
09/30/2020
28.90%
6Q
03/31/2022
06/30/2020
33.23%
7Q
03/31/2022
03/31/2020
34.68%
8Q
Load More

Period of Report: 03/31/2022

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2021
12.74%
2Q
03/31/2021
15.20%
4Q
12/31/2020
26.06%
5Q
09/30/2020
28.90%
6Q
06/30/2020
33.23%
7Q
03/31/2020
34.68%
8Q
Load More